Millennium Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Millennium Management's HAE Position: Q3 2026 in Review
Millennium Management increased its Haemonetics (HAE) stake by 12% in Q3 2026, buying an estimated $6.19M and bringing the position to 636,895 shares worth $67.1M. The position accounts for 0.02% of the portfolio, ranked #725.
Millennium Management first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $86.6M in Q1 2018. 361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Millennium Management held 636,895 shares of Haemonetics worth $67.1M as of Q3 2026.
- Millennium Management bought 66,482 Haemonetics shares in Q3 2026, an estimated $6.19M.
- Haemonetics made up 0.02% of Millennium Management's portfolio in Q3 2026, its #725 holding.
- Millennium Management first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- Millennium Management's Haemonetics position peaked at $86.6M in Q1 2018.
- 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.